Oncternal Therapeutics, Inc. (ONCT)
NASDAQ: ONCT · Real-Time Price · USD
1.140
+0.060 (5.56%)
Nov 20, 2024, 4:00 PM EST - Market closed
Oncternal Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 2.16 | 0.79 | 1.49 | 4.32 | 3.38 | 2.43 | |
| Revenue Growth (YoY) | 227.92% | -47.32% | -65.47% | 27.85% | 39.18% | -3.81% | |
| Cost of Revenue | 25.09 | 29.75 | 32.98 | 24.09 | 12.54 | 10.16 | |
| Gross Profit | -22.93 | -28.97 | -31.49 | -19.77 | -9.17 | -7.73 | |
| Selling, General & Admin | 11.93 | 12.75 | 13.46 | 11.6 | 8.37 | 7.29 | |
| Operating Expenses | 11.93 | 12.75 | 13.46 | 11.6 | 8.37 | 7.29 | |
| Operating Income | -34.86 | -41.71 | -44.95 | -31.37 | -17.54 | -15.02 | |
| Interest & Investment Income | 1.38 | 2.24 | 0.78 | 0.03 | 0.02 | 0.19 | |
| Other Non Operating Income (Expenses) | - | - | - | - | - | -1.27 | |
| EBT Excluding Unusual Items | -33.48 | -39.48 | -44.17 | -31.33 | -17.53 | -16.1 | |
| Other Unusual Items | - | - | - | - | 0.3 | - | |
| Pretax Income | -34.58 | -39.48 | -44.17 | -31.33 | -17.23 | -34.19 | |
| Net Income | -34.58 | -39.48 | -44.17 | -31.33 | -17.23 | -34.19 | |
| Net Income to Common | -34.58 | -39.48 | -44.17 | -31.33 | -17.23 | -34.19 | |
| Shares Outstanding (Basic) | 3 | 3 | 3 | 2 | 1 | 1 | |
| Shares Outstanding (Diluted) | 3 | 3 | 3 | 2 | 1 | 1 | |
| Shares Change (YoY) | 1.60% | 11.79% | 6.65% | 142.90% | 96.58% | 187.64% | |
| EPS (Basic) | -11.69 | -13.43 | -16.79 | -12.71 | -16.97 | -66.20 | |
| EPS (Diluted) | -11.69 | -13.43 | -16.79 | -12.71 | -16.97 | -66.20 | |
| Free Cash Flow | -26.63 | -32.16 | -36.7 | -26.59 | -17.5 | -16.75 | |
| Free Cash Flow Per Share | -9.01 | -10.94 | -13.96 | -10.78 | -17.23 | -32.43 | |
| Gross Margin | - | - | - | - | -271.67% | - | |
| Operating Margin | -1613.10% | -5313.89% | -3016.58% | -726.91% | -519.76% | -619.38% | |
| Profit Margin | -1599.95% | -5029.17% | -2964.43% | -726.14% | -510.37% | -1409.81% | |
| Free Cash Flow Margin | -1232.39% | -4097.32% | -2463.36% | -616.20% | -518.37% | -690.56% | |
| EBIT | -34.86 | -41.71 | -44.95 | -31.37 | -17.54 | -15.02 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.